China Cord Blood Corp. (NYSE:CO)’s share price fell 1.1% on Monday . The stock traded as low as $5.23 and last traded at $5.23, with a volume of 104,576 shares changing hands. The stock had previously closed at $5.29.

Several research firms have weighed in on CO. Zacks Investment Research lowered China Cord Blood Corp. from a “hold” rating to a “sell” rating in a research note on Monday. TheStreet lowered China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $6.75.

The company has a 50 day moving average price of $5.32 and a 200-day moving average price of $5.84. The firm has a market cap of $384.73 million and a P/E ratio of 27.31.

China Cord Blood Corp. (NYSE:CO) last posted its quarterly earnings results on Monday, August 22nd. The company reported $0.03 EPS for the quarter, hitting analysts’ consensus estimates of $0.03. The business had revenue of $26 million for the quarter, compared to analyst estimates of $26.23 million. On average, equities research analysts forecast that China Cord Blood Corp. will post $0.15 EPS for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.